HEPATOCYTE GROWTH-FACTOR STIMULATES THE INVASION OF GALLBLADDER CARCINOMA CELL-LINES IN-VITRO

Citation
H. Li et al., HEPATOCYTE GROWTH-FACTOR STIMULATES THE INVASION OF GALLBLADDER CARCINOMA CELL-LINES IN-VITRO, Clinical & experimental metastasis, 16(1), 1998, pp. 74-82
Citations number
42
Categorie Soggetti
Oncology
ISSN journal
02620898
Volume
16
Issue
1
Year of publication
1998
Pages
74 - 82
Database
ISI
SICI code
0262-0898(1998)16:1<74:HGSTIO>2.0.ZU;2-R
Abstract
Human gallbladder cancer is highly malignant and its prognosis is usua lly poor depending on the extent of surrounding tissue invasion. We ex amined in vitro the invasive activity of four gallbladder cancer cell lines (GB-d1, GB-h3, GB-d2 and FU-GBC-1) in the absence or presence of hepatocyte growth factor (HGF). In type 1 collagen gel culture, HGF s timulated cell proliferation and induced an invasive phenotype of arbo rizing structures in GB-d1, GB-h3 and GB-d2. In a Matrigel invasion as say, invasion was also induced in three of these lines by HGF but not in FU-GBC-1. Cellular motility was, however, stimulated by HGF in all of the four cell lines to various extents. Zymography for proteolytic enzymes demonstrated high levels of type IV collagenase and urokinase- type plasminogen activator (u-PA) activity in GB-d1, GB-h3 and GB-d2 e ven in the absence of HGF. In the presence of HGF, the 72 kDa type IV collagenase (MMP-2) activity of GB-h3 and u-PA activities of GB-d1, GB -h3 and GB-d2 were enhanced. In contrast, the MMPs and PAs activities of FU-GBC-1 were faint irrespective of the addition of HGF. A Western blot analysis demonstrated higher levels of 190 kDa c-MET product (HGF receptor) of GB-d1, GB-h3 and GB-d2 than that of FU-GBC-1. The invasi on in the Matrigel assay stimulated by HGF was inhibited by protease i nhibitors, aprotinin and FOY-305, as well as by anti-HGF antibody. The se results thus suggest that, in addition to the importance of the pro teolytic activity, the cellular motility induced via the HGF/HGF-recep tor system is essential for the invasive progression of gallbladder ca rcinoma cells.